1-20 of 20
Daniel H. van Raalte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes

Petter Bjornstad, Ye Ji Choi, Carson Platnick, Susan Gross, Phoom Narongkiatikhun, Isabella Melena, Lauryn Remmers, Madison Baca, Grant Schutte, Tyler Dobbs, Tim Vigers, Laura Pyle, Lynette Driscoll, Kalie Tommerdahl, Jessica Kendrick, Helen C. Looker, Allison Dart, David Cherney, Daniel H. van Raalte, Anand Srivastava, Luping Li, Pottumarthi Prasad, Pierre Saulnier, Robert G. Nelson, Richard J. Johnson, Kristen J. Nadeau, Bjornstad Lab, Nicholas Becker, Kyla Best, Carissa Birznieks, Michelle Bui, Diego Carrasco, Daniel Casillas, Maureen Flynn, Audrey Gruszcynski, Lucy Hall, Madeline Harbour, Melissa Leroux, Kelly Nash, Nhung Nguyen, Emily Sell, Callyn Rountree-Jablin
Journal: Diabetes Care
Diabetes Care 2024;47(3):409–417
https://doi.org/10.2337/dc23-1818
Published: 28 December 2023
View article titled, Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes
Open the PDF for Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes in another window
Journal Articles

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes

Coco M. Fuhri Snethlage, Timothy J. McDonald, Richard D. Oram, Pleun de Groen, Elena Rampanelli, Alinda W.M. Schimmel, Frits Holleman, Sarah Siegelaar, Joost Hoekstra, Catherine B. Brouwer, Filip K. Knop, C. Bruce Verchere, Daniël H. van Raalte, Bart O. Roep, Max Nieuwdorp, Nordin M.J. Hanssen
Journal: Diabetes Care
Diabetes Care 2024;47(7):1114–1121
https://doi.org/10.2337/dc23-0776
Published: 03 August 2023
View article titled, Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes
Open the PDF for Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes in another window
Journal Articles

Age Ain’t Nothing But a Number . . . or Is It?

Maria J. Redondo, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2023;46(6):1135–1136
https://doi.org/10.2337/dci23-0013
Published: 23 May 2023
View article titled, Age Ain’t Nothing But a Number . . . or Is It?
Open the PDF for Age Ain’t Nothing But a Number . . . or Is It? in another window
Journal Articles

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Mark M. Smits, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2023;46(5):e120
https://doi.org/10.2337/dc23-0134
Published: 26 April 2023
View article titled, Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Open the PDF for Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390 in another window
Journal Articles

Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk—The HELIUS Study

Marleen Zethof, Charlotte M. Mosterd, Didier Collard, Henrike Galenkamp, Charles Agyemang, Max Nieuwdorp, Daniël H. van Raalte, Bert-Jan H. van den Born
Journal: Diabetes Care
Diabetes Care 2021;44(7):1692–1698
https://doi.org/10.2337/dc21-0230
Published: 18 May 2021
View article titled, Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk—The HELIUS Study
Open the PDF for Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk—The HELIUS Study in another window
Journal Articles

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial

Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar, Anne C. Hesp, Peter J. Greasley, Cecilia Karlsson, Ann Hammarstedt, Niki Arya, Daniël H. van Raalte, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2021;44(2):440–447
https://doi.org/10.2337/dc20-2604
Published: 14 December 2020
View article titled, Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial
Open the PDF for Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial in another window
Journal Articles

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

Marcel H.A. Muskiet, Lennart Tonneijck, Mark M. Smits, Mark H.H. Kramer, D. Margriet Ouwens, Bolette Hartmann, Jens J. Holst, Daan J. Touw, A.H. Jan Danser, Jaap A. Joles, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2020;43(11):2889–2893
https://doi.org/10.2337/dc20-0902
Published: 08 September 2020
View article titled, Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial
Open the PDF for Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial in another window
Journal Articles

Sleep and HbA1c in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most?

Annelies Brouwer, Daniel H. van Raalte, Femke Rutters, Petra J.M. Elders, Frank J. Snoek, Aartjan T.F. Beekman, Marijke A. Bremmer
Journal: Diabetes Care
Diabetes Care 2020;43(1):235–243
https://doi.org/10.2337/dc19-0550
Published: 12 December 2019
View article titled, Sleep and HbA<sub>1c</sub> in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most?
Open the PDF for Sleep and HbA<sub>1c</sub> in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most? in another window
Includes: Supplementary data
Journal Articles

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function

Erik J.M. van Bommel, Danique Ruiter, Marcel H.A. Muskiet, Michaël J.B. van Baar, Mark H.H. Kramer, Max Nieuwdorp, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2020;43(1):228–234
https://doi.org/10.2337/dc19-1651
Published: 29 October 2019
View article titled, Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function
Open the PDF for Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function in another window
Includes: Supplementary data
Journal Articles

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556

Michaël J.B. van Baar, Charlotte C. van Ruiten, Marcel H.A. Muskiet, Liselotte van Bloemendaal, Richard G. IJzerman, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2019;42(10):2015
https://doi.org/10.2337/dc19-er10a
Published: 20 August 2019
View article titled, Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556
Open the PDF for Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41: 1543–1556 in another window
Journal Articles

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

Daniël H. van Raalte, Petter Bjornstad, Frederik Persson, David R. Powell, Rita de Cassia Castro, Ping Stella Wang, Minzhi Liu, Hiddo J.L. Heerspink, David Cherney
Journal: Diabetes Care
Diabetes Care 2019;42(10):1921–1929
https://doi.org/10.2337/dc19-0937
Published: 01 August 2019
View article titled, The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
Open the PDF for The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial

Annelies Brouwer, Daniel H. van Raalte, Hoang-Ton Nguyen, Femke Rutters, Peter M. van de Ven, Petra J.M. Elders, Annette C. Moll, Eus J.W. Van Someren, Frank J. Snoek, Aartjan T.F. Beekman, Marijke A. Bremmer
Journal: Diabetes Care
Diabetes Care 2019;42(4):529–538
https://doi.org/10.2337/dc18-1732
Published: 11 March 2019
View article titled, Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial
Open the PDF for Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaela Diamant, Jaap A. Joles, Daniel H. van Raalte
Journal: Diabetes Care
Diabetes Care 2019;42(3):494
https://doi.org/10.2337/dc19-er03
Published: 23 January 2019
View article titled, Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050
Open the PDF for Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050 in another window
Journal Articles

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

Michaël J.B. van Baar, Charlotte C. van Ruiten, Marcel H.A. Muskiet, Liselotte van Bloemendaal, Richard G. IJzerman, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2018;41(8):1543–1556
https://doi.org/10.2337/dc18-0588
Published: 11 July 2018
View article titled, SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
Open the PDF for SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management in another window
Journal Articles

Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073–1081

Michaël J.B. van Baar, Daniël H. van Raalte, Marcel H.A. Muskiet
Journal: Diabetes Care
Diabetes Care 2017;40(11):e157–e158
https://doi.org/10.2337/dc17-1258
Published: 12 October 2017
View article titled, Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073–1081
Open the PDF for Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073–1081 in another window
Journal Articles

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial

Mark M. Smits, Lennart Tonneijck, Marcel H.A. Muskiet, Mark H.H. Kramer, Indra C. Pieters-van den Bos, Karuna E.W. Vendrik, Trynke Hoekstra, Marco J. Bruno, Michaela Diamant, Daniël H. van Raalte, Djuna L. Cahen
Journal: Diabetes Care
Diabetes Care 2017;40(3):301–308
https://doi.org/10.2337/dc16-0836
Published: 20 December 2016
View article titled, Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial
Open the PDF for Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaela Diamant, Jaap A. Joles, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2016;39(11):2042–2050
https://doi.org/10.2337/dc16-1371
Published: 01 September 2016
View article titled, Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Open the PDF for Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels

Mark M. Smits, Mathijs C. Bunck, Michaela Diamant, Anja Corner, Bjorn Eliasson, Robert J. Heine, Ulf Smith, Hannele Yki-Järvinen, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2016;39(3):e42–e43
https://doi.org/10.2337/dc15-2489
Published: 30 December 2015
View article titled, Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels
Open the PDF for Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels in another window
Journal Articles

Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089–1098

Mark M. Smits, Marcel H.A. Muskiet, Lennart Tonneijck, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2015;38(7):e106–e107
https://doi.org/10.2337/dc15-0367
Published: 11 June 2015
View article titled, Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089–1098
Open the PDF for Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089–1098 in another window
Journal Articles

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

Daniël H. van Raalte, MD, Renate E. van Genugten, MD, Margot M.L. Linssen, MSC, D. Margriet Ouwens, PHD, Michaela Diamant, MD
Journal: Diabetes Care
Diabetes Care 2011;34(2):412–417
https://doi.org/10.2337/dc10-1677
Published: 20 January 2011
View article titled, Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans
Open the PDF for Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans in another window
Includes: Supplementary data